-
-
-
-
-
-
-
Cytosorbents (CTSO) Submits DrugSorb-ATR Marketing Application to U.S. FDA
-
-
-
-
-
-
-
Cytosorbents (CTSO) Pivotal STAR-T Trial Reaches Second Key Milestone
-
-
-
-
-
-
-
Cytosorbents (CTSO), Aferetica Launch PerSorb Adsorber and PerLife Organ Perfusion System in Italy
-
-
-
-
-
-
-
Cytosorbents (CTSO) Announces Proposed $40 Million Public Offering of Common Stock
-
-
-
-
-
-
-
Pre-Open Movers 03/31: (SORL) (BBRY) (BDSI) Higher; (DRIO) (BLRX) (CTSO) Lower (more...)
-
-
68,144 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

